Brian Rosenberger - Net Worth and Insider Trading
Brian Rosenberger Net Worth
The estimated net worth of Brian Rosenberger is at least $324,427 dollars as of 2024-12-03. Brian Rosenberger is the VP, Commercial & Business Dev. of Zynerba Pharmaceuticals Inc and owns about 249,559 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $324,427. Details can be seen in Brian Rosenberger's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Rosenberger has not made any transactions after 2023-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Rosenberger
Brian Rosenberger Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Rosenberger owns 1 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) .
Click here to see the complete history of Brian Rosenberger’s form 4 insider trades.
Insider Ownership Summary of Brian Rosenberger
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-09-13 | VP & Commercial & Business Dev. |
Brian Rosenberger Latest Holdings Summary
Brian Rosenberger currently owns a total of 1 stock. Brian Rosenberger owns 249,559 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of September 13, 2023, with a value of $324,427.
Latest Holdings of Brian Rosenberger
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZYNE | Zynerba Pharmaceuticals Inc | 2023-09-13 | 249,559 | 1.30 | 324,427 |
Holding Weightings of Brian Rosenberger
Brian Rosenberger Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Rosenberger has made a total of 3 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 6,411 shares on September 13, 2023, which brought Brian Rosenberger around $8,527.
Insider Trading History of Brian Rosenberger
- 1
Brian Rosenberger Trading Performance
Brian Rosenberger Ownership Network
Brian Rosenberger Owned Company Details
What does Zynerba Pharmaceuticals Inc do?
Who are the key executives at Zynerba Pharmaceuticals Inc?
Brian Rosenberger is the VP & Commercial & Business Dev. of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include Chief Financial Officer James E Fickenscher , director & Chairman & Chief Exec. Officer Armando Anido , and President Terri B Sebree .
Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary
Over the past 18 months, Brian Rosenberger made 1 insider transaction in Zynerba Pharmaceuticals Inc (ZYNE) with a net sale of 6,411. Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 17,830 shares made by Armando Anido , a net sale of 12,401 shares made by Terri B Sebree , and a net sale of 8,998 shares made by James E Fickenscher .
In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 48,835 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,835 shares.
Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zynerba Pharmaceuticals Inc Insider Transactions
Brian Rosenberger Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Rosenberger. You might contact Brian Rosenberger via mailing address: C/o Zynerba Pharmaceuticals, Inc., 80 West Lancaster Avenue, Suite 300, Devon Pa 19333.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
